Home/Filings/4/0001562180-23-004169
4//SEC Filing

Hadas Nicole R. 4

Accession 0001562180-23-004169

CIK 0001517022other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:10 PM ET

Size

5.0 KB

Accession

0001562180-23-004169

Insider Transaction Report

Form 4
Period: 2023-05-12
Hadas Nicole R.
VP General Counsel & Secretary
Transactions
  • Award

    Common Stock

    2023-05-12+100,000387,530 total
Footnotes (1)
  • [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Issuer

Akebia Therapeutics, Inc.

CIK 0001517022

Entity typeother

Related Parties

1
  • filerCIK 0001602396

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:10 PM ET
Size
5.0 KB